Value202220232024TTMSelling/general/admin expenses————Research & development————Operating income————Non-Operating Income, Total————Interest expense, net of interest capitalized————Non-Operating Income, excl. Interest Expenses————Unusual income/expense————Pretax income————Equity in earnings————Taxes————Non-controlling/minority interest————After tax other income/expense————Net income before discontinued operations————Discontinued operations————Net income————Dilution adjustment————Preferred dividends————Diluted net income available to common stockholders————Basic earnings per share (Basic EPS)————Diluted earnings per share (Diluted EPS)————Average basic shares outstanding————Diluted shares outstanding————EBITDA————EBIT————Cost of revenue————Other cost of goods sold————Depreciation & amortization (cash flow)————
Haleon plc American Depositary Shares (Each representing two Or
Haleon plc is a British multinational consumer healthcare company with headquarters in Weybridge, England. It is one of the largest consumer healthcare businesses in the world, with brands including Sensodyne toothpaste, Panadol and Advil painkillers, and Centrum vitamins. The company was projected to be a global leader in over the counter medicines with a 7.3 per cent market share in 2022.
Haleon was established on 18 July 2022 as a corporate spin-off from GSK. Haleon is listed on the London Stock Exchange and is a component of the FTSE 100, with a secondary listing on the New York Stock Exchange.